Tenet Healthcare (THC) Cash & Equivalents (2009 - 2026)

Tenet Healthcare (THC) has 18 years of Cash & Equivalents data on file, last reported at $3.0 billion in Q1 2026.

• Quarterly Cash & Equivalents fell 1.07% year-over-year to $3.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 billion (down 1.07% YoY) and the FY2025 annual result came in at $2.9 billion, down 4.5% from the prior year.
• Cash & Equivalents rose to $3.0 billion in Q1 2026 per THC's latest filing, from $2.9 billion in the prior quarter.
• The five-year high for Cash & Equivalents was $4.1 billion in Q3 2024, with the low at $766.0 million in Q1 2023.
• Average Cash & Equivalents over 5 years is $2.1 billion, with a median of $2.5 billion recorded in 2024.
• Year-over-year, Cash & Equivalents slumped 63.71% in 2022 and soared 288.43% in 2024.
• Tenet Healthcare's Cash & Equivalents stood at $858.0 million in 2022, then jumped by 43.12% to $1.2 billion in 2023, then surged by 145.85% to $3.0 billion in 2024, then declined by 4.5% to $2.9 billion in 2025, then rose by 2.91% to $3.0 billion in 2026.
• Business Quant data shows THC's Cash & Equivalents at $3.0 billion in Q1 2026, $2.9 billion in Q4 2025, and $3.0 billion in Q3 2025.